Earnings · China A-shares
Zhejiang Anglikang Pharmaceutical Co. Ltd. Class A (002940) earnings
Zhejiang Anglikang Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-28: net profit -19.41% year on year, -20.30% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +0.60% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -19.41%
- Excl. one-offs YoY
- -20.30%
- Net profit QoQ
- -79.39%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -5.67% | — |
| 3 days | +0.60% | — |
| 7 days | +14.95% | — |
| 14 days | -4.90% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 3 of 7 reports (average -1.18%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥62.61M | -19.41% | -20.30% | -14.69% | 0.31 | 3.80% | +0.60% | — | — |
| 2026 interim report | 2026-08-25 | ¥54.93M | -16.68% | -15.77% | -13.44% | 0.27 | 3.33% | +2.25% | -12.73% | -6.71% |
| 2026 Q1 report | 2026-04-29 | ¥17.65M | +10.99% | +82.96% | -1.55% | 0.09 | 1.08% | -6.22% | -21.33% | -22.28% |
| 2025 annual report | 2026-04-29 | ¥125.44M | +56.15% | +78.82% | -7.35% | 0.62 | 7.93% | -6.22% | -21.33% | -22.28% |
| 2025 Q3 report | 2025-10-25 | ¥77.69M | +55.59% | +39.70% | -5.92% | 0.39 | 4.99% | -3.09% | -3.65% | -3.43% |
| 2025 interim report | 2025-08-28 | ¥65.93M | -3.19% | -26.77% | -14.52% | 0.33 | 4.24% | -2.10% | -12.51% | -18.01% |
| 2025 Q1 report | 2025-04-30 | ¥15.91M | -43.63% | -59.39% | -15.31% | 0.08 | 1.03% | +0.81% | +114.42% | +111.25% |
| 2024 annual report | 2025-04-26 | ¥80.33M | -41.94% | -54.71% | -5.41% | 0.40 | 5.05% | -0.52% | +101.64% | +98.39% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.